2 research outputs found
Metabolic outcomes in the first year after laparoscopic sleeve gastrectomy: a high-volume single-center experience
OBJECTIVE: Laparoscopic sleeve gastrectomy (LSG) is the most preferred bariatric surgical procedure worldwide. LSG, a restrictive surgical method, has also proven to be a good metabolic surgery option. In this study, we examined weight loss and changes in metabolic parameters in our patients in the first year after LSG.
PATIENTS AND METHODS: In this retrospective cohort study, preoperative and postoperative first-year body mass index (BMI) changes, biochemical and hormonal analysis results, and excess weight loss (EWL) rates of 1,137 patients who underwent LSG were evaluated.
RESULTS: The median age of patients undergoing LSG was 39 years, and 943 (82.9%) of the patients were female while 194 (17.1%) were male. Preoperative BMI was 45.91 kg/m2 and postoperative first-year BMI was 28.98 kg/m2 (p46.87 kg/m2 had a higher rate of adequate weight loss.
CONCLUSIONS: LSG is a bariatric surgical procedure providing satisfactory weight loss and metabolic outcomes in the short term. Weight loss success in the first year after LSG was higher among patients with a baseline BMI of 46 kg/m2
Identifying Clinical Characteristics of Hypoparathyroidism in Turkey: HIPOPARATURK-NET Study
Hypoparathyroidism is an orphan disease with ill-defined epidemiology that is subject to geographic variability. We conducted this study to assess the demographics, etiologic distribution, treatment patterns and complication frequency of patients with chronic hypoparathyroidism in Turkey. This is a retrospective, cross-sectional database study, with collaboration of 30 endocrinology centers located in 20 cities across seven geographical regions of Turkey. A total of 830 adults (mean age 49.6 ± 13.5 years; female 81.2%) with hypoparathyroidism (mean duration 9.7 ± 9.0 years) were included in the final analysis. Hypoparathyroidism was predominantly surgery-induced (n = 686, 82.6%). The insulting surgeries was carried out mostly due to benign causes in postsurgical group (SG) (n = 504, 73.5%) while patients in nonsurgical group (NSG) was most frequently classified as idiopathic (n = 103, 71.5%). The treatment was highly dependent on calcium salts (n = 771, 92.9%), calcitriol (n = 786, 94.7%) and to a lower extent cholecalciferol use (n = 635, 76.5%) while the rate of parathyroid hormone (n = 2, 0.2%) use was low. Serum calcium levels were most frequently kept in the normal range (sCa 8.5–10.5 mg/dL, n = 383, 46.1%) which might be higher than desired for this patient group. NSG had a lower mean plasma PTH concentration (6.42 ± 5.53 vs. 9.09 ± 7.08 ng/l, p < 0.0001), higher daily intake of elementary calcium (2038 ± 1214 vs. 1846 ± 1355 mg/day, p = 0.0193) and calcitriol (0.78 ± 0.39 vs. 0.69 ± 0.38 mcg/day, p = 0.0057), a higher rate of chronic renal disease (9.7% vs. 3.6%, p = 0.0017), epilepsy (6.3% vs. 1.6%, p = 0.0009), intracranial calcifications (11.8% vs. 7.3%, p < 0.0001) and cataracts (22.2% vs. 13.7%, p = 0.0096) compared to SG. In conclusion, postsurgical hypoparathyroidism is the dominant etiology of hypoparathyroidism in Turkey while the nonsurgical patients have a higher disease burden with greater need for medications and increased risk of complications than the postsurgical patients. © 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature